I will do the same. One thing I have been thinking about has been the issuance of those shares and warrants. I think it might be a block of a hostile takeover threat. At Stellar's current price if Uracyst had good phase II results, it would make sense for Watson to just acquire Stellar. If those warrants and shares went to friendly parties they would be bumping right up against 50% ownership.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.